Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma (Q62725074)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

corrigendum / erratum

Erratum to “Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma” [Gynecol Oncol. 120 (2011) 11–17]

0 references

author

Heini Lassus

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Synnöve Staff

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Arto Leminen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Jorma Isola

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Ralf Butzow

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

English

0 references

publication date

1 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

11-17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937525%20AND%20SRC:MED&resulttype=core&format=json

Roles of Aurora kinases in mitosis and tumorigenesis.

15 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Aurora A overexpression induces cellular senescence in mammary gland hyperplastic tumors developed in p53-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Aurora-A, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Aurora kinases as anticancer drug targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Predictive value of Aurora-A/STK15 expression for late stage epithelial ovarian cancer patients treated by adjuvant chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Aurora kinases as prognostic biomarkers in ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Tissue microarrays for high-throughput molecular profiling of tumor specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Distinct subtypes of serous ovarian carcinoma identified by p53 determination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Identification of phosphorylated residues that affect the activity of the mitotic kinase Aurora-A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Correlation of mRNA and protein in complex biological samples.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Analysis of prognostic factors in stage I epithelial ovarian carcinoma: importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

Cellular DNA content and survival in advanced ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.003

10.1016/J.YGYNO.2010.09.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20937525%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference